Delivery Order SPE2DB22D2211-SPE2DB25FSCWD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,004.52 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,361.80 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations. This competitive award uses firm fixed pricing with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,073.16 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $20,171.71 delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL format, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $35,602.74 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL format. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of August 14, 2025. The delivery order was issued on August 13, 2025, as a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $18,198.96 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. The contract was competitively awarded with firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $39,761.82 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,621.17 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This competitively awarded, firm fixed-price delivery order is set to be completed by August 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $8,761.83. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 billion through December 2026. The award was made through competitive procedures with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $18,920.72 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 4, 2025. The award leverages AmerisourceBergen's position as a prime vendor under the Defense Logistics Agency's Troop Support Medical indefinite delivery contract (SPE2DX), valued...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCWDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,224.78 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This firm fixed price, competitively awarded delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that enables the company to supply comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company has demonstrated capability to meet federal procurement requirements through competitive awards across a diverse portfolio of pharmaceutical products, including specialty medications, vaccines, and medical devices. This delivery order for Ozempic, a diabetes management medication, exemplifies the company's role in supplying essential brand-name pharmaceuticals to support military and veteran healthcare needs through the DLA's global pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/13/25 |